News & Events

Dr. Frank Wagner, CEO & Chief Scientific Officer will be speaking at the 12th Annual Phase I Clinical Trials conference on Tuesday 15th February 2011.

Dr. Wagner will be speaking on the topic “Effectively leveraging university hospital expertise and resources to accelerate exploratory clinical development”. The presentation will highlight some of the thinking behind the establishment of Charité Research Organisation and how going beyond the traditional CRO/hospital collaboration has been able to speed the transition from FTIH to POC.

Charité Research Organisation will be attending the 2011 Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) in Dallas, 2-5 March 2011.